PROLONGED REMISSION OF PLATINUM-REFRACTORY OVARIAN-CANCER WITH DOCETAXEL - BRIEF REPORT AND REVIEW OF LITERATURE

Platinum-based chemotherapy is the standard treatment for ovarian canc er, with response rates of 70-80%. Docetaxel has an increasing role as salvage therapy in patients with platinum-refractory ovarian cancer. In this report, we present the case of a patient with platinum-refract ory ovarian cancer who achieved a long-term complete remission with do cetaxel therapy. Two years after completion of chemotherapy with docet axel, she continues to have no evidence of disease.